These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2246310)

  • 1. Cyclosporine A for prolonging allograft survival in patients with massive burns.
    Sakabu SA; Hansbrough JF; Cooper ML; Greenleaf G
    J Burn Care Rehabil; 1990; 11(5):410-8. PubMed ID: 2246310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine-induced long-term allograft survival and its potential in posttrauma tissue replacement.
    Black KS; Hewitt CW; Henson LE; Chau LC; Pizzo L; Achauer BM
    J Burn Care Rehabil; 1987; 8(6):531-5. PubMed ID: 3325513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fate of meshed allograft skin in burned patients using cyclosporin immunosuppression.
    Frame JD; Sanders R; Goodacre TE; Morgan BD
    Br J Plast Surg; 1989 Jan; 42(1):27-34. PubMed ID: 2645003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced allograft survival in H-2 compatible cyclosporine-treated mice.
    Krob MJ; Shelby J
    J Trauma; 1988 Feb; 28(2):225-7. PubMed ID: 3279221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged allograft survival in a patient with extensive burns using cyclosporin.
    Mindikoğlu AN; Cetinkale O
    Burns; 1993 Feb; 19(1):70-2. PubMed ID: 8435121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival.
    Oluwole SF; Lau HT; Reemtsma K; Hardy MA
    Transplantation; 1988 Feb; 45(2):293-7. PubMed ID: 3278417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy.
    Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
    Transplantation; 1989 Jan; 47(1):96-102. PubMed ID: 2643236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of severe burns with widely meshed skin autograft and meshed skin allograft overlay.
    Alexander JW; MacMillan BG; Law E; Kittur DS
    J Trauma; 1981 Jun; 21(6):433-8. PubMed ID: 7230295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of bromocryptine-induced hypoprolactinemia on xenogeneic and allogeneic skin graft survival in a mouse model.
    Compton CC; Rizk I; Regauer S; Burd E; Holaday J; Kenner J
    J Burn Care Rehabil; 1994; 15(5):393-400. PubMed ID: 7995809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine and skin allografts for the treatment of thermal injury. I. Extensive graft survival with low-level long-term administration and prolongation in a rat burn model.
    Hewitt CW; Black KS; Aguinaldo AM; Achauer BM; Howard EB
    Transplantation; 1988 Jan; 45(1):8-12. PubMed ID: 3276067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for second renal allografts immunosuppressed with cyclosporine.
    Almond PS; Matas AJ; Gillingham K; Troppmann C; Payne W; Dunn D; Sutherland D; Najarian JS
    Transplantation; 1991 Aug; 52(2):253-8. PubMed ID: 1871798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term skin allograft survival after short-term cyclosporin treatment in a patient with massive burns.
    Achauer BM; Hewitt CW; Black KS; Martinez SE; Waxman KS; Ott RA; Furnas DW
    Lancet; 1986 Jan; 1(8471):14-5. PubMed ID: 2867262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial and detrimental effects of RBC-adsorbed antilymphocyte globulin and prednisone on purified canine islet autograft and allograft function.
    Kaufman DB; Morel P; Condie R; Field MJ; Rooney M; Tzardis P; Stock P; Sutherland DE
    Transplantation; 1991 Jan; 51(1):37-42. PubMed ID: 1987703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy.
    Hirsch RL; Layton PC; Barnes LA; Kremer AB; Goldstein G
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):32-6. PubMed ID: 3105138
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term survival of human skin allografts in patients with immunosuppression.
    Wendt JR; Ulich T; Rao PN
    Plast Reconstr Surg; 2004 Apr; 113(5):1347-54. PubMed ID: 15060346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved large burn therapy with reduced mortality following an associated septic challenge by early excision and skin allografting using donor-specific tolerance.
    Garrison JL; Thomas F; Cunningham P
    Transplant Proc; 1995 Feb; 27(1):1416-8. PubMed ID: 7878931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifying cyclosporine associated renal allograft dysfunction.
    Mohapatra N; Vanikar AV; Patel RD; Trivedi HL
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):770-4. PubMed ID: 19736471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG; Henry M; Ferguson RM
    Transplantation; 1987 Jan; 43(1):85-90. PubMed ID: 3541330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.